糖尿病伴血脂异常患者的社区治疗策略.pptVIP

* LDL-C是个重要危险因素, 但HDL-C,SBP, HbA1c同样是心血管危险预测的重要因素. * 我国建议 * * 2006年BMJ上一篇关于同时入选糖尿病和非糖尿病患者降脂研究荟萃分析显示, 降脂研究(绝大部分是他汀研究)可以显著降低糖尿病和非糖尿病患者的心血管风险. 而糖尿病患者无论在一级预防还是二级预防中获益更多. The evidence that lipid lowering drug treatment (especially statins) significantly reduce cardiovascular risk in diabetic and non-diabetic patients is strong and suggests that diabetic patients benefit more, in both primary and secondary prevention. * UKPDS clearly demonstrated that in addition to important glucose control for reducing microvascular complications, LDL-C is a primary target for reducing CHD risk in patients with